FBR Capital Markets Comments on Shire PLC Following Announcement of ViroPharma Acquisition


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


In a report published Tuesday, FBR Capital Markets analyst William Tanner commented on recent developments related to

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Shire PLC (NASDAQ: SHPG).In the report, FBR Capital Markets noted, “The announcement that Shire plans to acquire ViroPharma probably comes as little surprise to many investors, given expectations over the past few months that such a move might occur. We view the acquisition, particularly Cinryze, as a logical complement to Shire's Orphan disease business, in general, and a focus on HAE, specifically. In addition to the restructuring activity, we expect Shire to continue to seek new commercial opportunities, as well as to divest business lines that may no longer be viewed as core or that are underperforming.”Shire PLC closed on Monday at $135.33.
Posted In: Analyst ColorAnalyst RatingsFBR Capital MarketsWilliam Tanner